These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2095129

  • 1. Chelators affecting iron absorption in mice.
    Kontoghiorghes GJ.
    Arzneimittelforschung; 1990 Dec; 40(12):1332-5. PubMed ID: 2095129
    [Abstract] [Full Text] [Related]

  • 2. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ.
    Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
    [Abstract] [Full Text] [Related]

  • 3. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D, Ponka P, Baker E.
    Cancer Res; 1994 Feb 01; 54(3):685-9. PubMed ID: 8306330
    [Abstract] [Full Text] [Related]

  • 4. The inhibitory action of chlorogenic acid on the intestinal iron absorption in rats.
    Gutnisky A, Rizzo N, Castro ME, Garbossa G.
    Acta Physiol Pharmacol Ther Latinoam; 1992 Feb 01; 42(3):139-46. PubMed ID: 1343584
    [Abstract] [Full Text] [Related]

  • 5. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH, Licéaga J, Arthur HM, Kontoghiorghes GJ.
    Am J Hematol; 1990 May 01; 34(1):21-5. PubMed ID: 2327400
    [Abstract] [Full Text] [Related]

  • 6. Mobilisation of recently absorbed 59Fe in ex vivo perfused rat duodena and the influence of iron status and subsequently absorbed chelators.
    Ettle T, Elsenhans B, Windisch W, Srai SK, Schümann K.
    J Trace Elem Med Biol; 2006 May 01; 19(4):231-41. PubMed ID: 16443171
    [Abstract] [Full Text] [Related]

  • 7. Assessing and influencing the fractional contribution of erythrocyte-bound 59Fe to individual 59Fe tissue content in murine 59Fe distribution studies.
    Szegner B, Herbach N, Ettle T, Elsenhans B, Schümann K.
    Toxicology; 2008 Feb 28; 244(2-3):198-208. PubMed ID: 18191885
    [Abstract] [Full Text] [Related]

  • 8. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
    Kontoghiorghes GJ, Sheppard L, Chambers S.
    Arzneimittelforschung; 1987 Oct 28; 37(10):1099-102. PubMed ID: 3435580
    [Abstract] [Full Text] [Related]

  • 9. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr 28; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 10. The effect of chronic ethanol consumption on iron absorption in rats.
    Mazzanti R, Srai KS, Debnam ES, Boss AM, Gentilini P.
    Alcohol Alcohol; 1987 Apr 28; 22(1):47-52. PubMed ID: 3593483
    [Abstract] [Full Text] [Related]

  • 11. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L.
    Am J Hematol; 1993 Apr 28; 42(4):340-9. PubMed ID: 8493983
    [Abstract] [Full Text] [Related]

  • 12. Zinc and iron interactions evaluated between different mineral sources in different nutritional matrixes.
    Boccio J, Salgueiro J, Zubillaga M, Lysionek A, Caro R, Antoine J, Weill R.
    Food Nutr Bull; 2002 Sep 28; 23(3 Suppl):195-8. PubMed ID: 12362794
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu Z, Hider RC.
    J Med Chem; 1998 Aug 27; 41(18):3347-59. PubMed ID: 9719587
    [Abstract] [Full Text] [Related]

  • 14. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine.
    Barrand MA, Callingham BA, Hider RC.
    J Pharm Pharmacol; 1987 Mar 27; 39(3):203-11. PubMed ID: 2883285
    [Abstract] [Full Text] [Related]

  • 15. New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.
    Kontoghiorghes GJ, Kolnagou A, Demetriou T, Neocleous M, Kontoghiorghe CN.
    Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34074010
    [Abstract] [Full Text] [Related]

  • 16. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
    Barrand MA, Callingham BA.
    Br J Pharmacol; 1991 Feb 24; 102(2):408-14. PubMed ID: 2015422
    [Abstract] [Full Text] [Related]

  • 17. Separation of cellular iron containing compounds by electrophoresis.
    Vyoral D, Petrák J, Hradilek A.
    Biol Trace Elem Res; 1998 Mar 24; 61(3):263-75. PubMed ID: 9533565
    [Abstract] [Full Text] [Related]

  • 18. A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly.
    Schümann K, Szegner B, Kohler B, Pfaffl MW, Ettle T.
    Toxicology; 2007 Nov 20; 241(1-2):19-32. PubMed ID: 17868968
    [Abstract] [Full Text] [Related]

  • 19. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP, Jones HM, Abeysinghe RD, Hider RC, Porter JB.
    Exp Hematol; 1993 Jan 20; 21(1):86-92. PubMed ID: 8417963
    [Abstract] [Full Text] [Related]

  • 20. 59Fe distribution and elimination after melanin administration in mice.
    Nogaj P, Gołek A, Bogacz A, Piatek K, Buszman E, Mossae IB.
    Acta Biochim Pol; 1992 Jan 20; 39(1):89-94. PubMed ID: 1441842
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.